center field = 3438 G
Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Over half (57%) said they actively caution patients against getting GLP-1s from virtual providers, with their main concerns being overprescribing and lack of continuity of care
In the United Kingdom, the prescribing and dispensing of medicines is governed by the MHRA, and all licensed medicines must hold a valid marketing authorisation before they can be routinely prescribed
theyre usually just repackaged weight loss supplements marketed under a new name. She adds that what people describe as success is more likely due to belief rather than biology: Any results people notice are far more likely due to the placebo effectwhen you believe something will help, you may naturally start making healthier choices, like eating more mindfully or being more active, which can lead to weight loss on its own
your health deserves the expertise of licensed professionals who understand proper dosing, sterile techniques, and how to monitor your response